Primary Care of Children and Adolescents with Down Syndrome: An Update

Current Problems in Pediatric and Adolescent Health Care

Volumn 38, Issue 8, 2008, Pages 241-261

  Baum, Rebecca A ^a   Nash, Patricia L ^a   Foster, Jessica E A ^a   Spader, Michelle ^a   Ratliff Schaub, Karen ^a   Coury, Daniel L ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC ACID; PIRACETAM; PYRIDOXINE; RETINOL; RIVASTIGMINE; THIAMINE;

ADOLESCENT; AGGRESSION; ALTERNATIVE MEDICINE; ARTICLE; BEHAVIOR DISORDER; BLOOD DISEASE; BONE DISEASE; CELL THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILD HEALTH CARE; CHROMOSOME 21; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; DECREASED APPETITE; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOCTOR PATIENT RELATION; DOWN SYNDROME; EAR NOSE THROAT DISEASE; EARLY DIAGNOSIS; EARLY INTERVENTION; FACE MALFORMATION; GASTROINTESTINAL DISEASE; GROWTH DISORDER; HEALTH CARE DELIVERY; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOLOGY; INTERPERSONAL COMMUNICATION; LANGUAGE DISABILITY; MATERNAL AGE; MENTAL DISEASE; MOLECULAR GENETICS; OUTCOME ASSESSMENT; PATIENT ADVOCACY; PHENOTYPIC VARIATION; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIMARY HEALTH CARE; PSYCHOTHERAPY; RECURRENCE RISK; REPRODUCTIVE HEALTH; RISK FACTOR; SIDE EFFECT; SLEEP DISORDER; THYROID DISEASE; TRISOMY 21; VISUAL DISORDER;

ADOLESCENT; CHILD; DOWN SYNDROME; EDUCATIONAL STATUS; GENETIC SCREENING; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS; UNITED STATES;

EID: 49549113848     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cppeds.2008.07.001     Document Type: Article

References (93)

1. Lejeune J., Gaustier M., and Turpin R. A study of somatic chromosomes in nine infants with mongolism. Acad Sci Paris 240 (1959) 1026-1027
2. Peterson M.B., and Mikkelsen M. Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet 91 (2000) 199-203
3. Canfield M.A., Ramadhani T.A., Yuskiv N., et al. Centers for Disease Control and Prevention. Improved national prevalence estimates for 18 selected major birth defects-United States, 1999-2001. MMWR Morb Mortal Wkly Rep 54 (2006) 1301-1305
4. Sherman S.L., Freeman S.B., Allen E.G., and Lamb N.E. Risk factors for nondisjuntion of trisomy 21. Cytogenet Genome Res 111 (2005) 273-280
5. Capone G.T. Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr 22 (2001) 40-59
6. American Academy of Pediatrics. Health supervision for children with Down syndrome. Pediatrics 107 (2001) 442-449
7. Cohen W.I. Down syndrome: care of the child and family. In: Levine M.D., Carey W.B., and Crocker A.C. (Eds). Developmental-behavioral pediatrics. 3rd Edition (1999), W.B. Saunders, Philadelphia 240-248
8. ACOG Practice Bulletin. Invasive prenatal testing for aneuploidy. Obstet Gynecol 110 (2007) 1459-1467
9. Roizen N.J., and Patterson D. Down's syndrome. Lancet 361 (2003) 1281-1289
10. Tolmie J.L. Down syndrome and other autosomal trisomies. In: Rimoin D.L., Connor J.M., Pyeritz R.E., and Korf B.R. (Eds). Emery and Rimoin's principles and practice of medical genetics. 4th Edition (2002), Churchill Livingstone, London 1129-1183
11. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
12. Warburton D., Dallaire L., Thangavelu M., Ross L., Levin B., and Kline J. Trisomy recurrence: a reconsideration based on North American data. Am J Hum Genet 75 (2004) 376-385
13. Nussbaum R.L., McInnes R.R., and Willard H.F. Thompson and Thompson genetics in medicine. 6th Revised Reprint Edition (2004), W.B. Saunders, Philadelphia
14. ACOG Practice Bulletin. Screening for fetal chromosome abnormalities. Obstet Gynecol 109 (2007) 217-227
15. Wildschut H.I.J., Peters T.J., and Weiner C.P. Screening in women's health, with emphasis on fetal Down's Syndrome, breast cancer, and csteoporosis. Hum Reprod Update 12 (2006) 499-512
16. Canick J.A., and MacRae A.R. Second trimester serum markers. Semin Perinatol 29 (2005) 203-208
17. Reddy U.M., and Menutti M.T. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institutes of Child Health and Human Developmental workshop. Obstet Gynecol 107 (2006) 167-173
18. Estroff J.A. Prenatal diagnosis and imaging of genetic syndromes. Semin Roentgenol 39 (2004) 323-335
19. Mazza V., Pati M., Bertucci E., Re C., Ranzi A., Percesepe A., et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenat Diagn 27 (2007) 180-183
20. Olney R.S., Moore C.A., Khoury M.J., et al. Centers for Disease Control and Prevention. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR Recomm Rep 44 (1995) 1-12
21. Olsen C.L., and Cross P.K. Trends in the use of prenatal diagnosis in New York state and the impact of biochemical screening on the detection of Down Syndrome. Prenat Diagn 17 (1997) 1113-1124
22. Skotko B. Mothers of children with Down syndrome reflect on their postnatal support. Pediatrics 115 (2005) 64-77
23. Freeman S., Taft L., and Dooley K.J. Population-based study of congenital heart defects in Down Syndrome. Am J Med Genet 80 (1998) 213-217
24. In: Van Dyke D.C., Mattheis P., Schoon E.S., and Williams J. (Eds). Medical and surgical care for children with Down syndrome: A Guide for Parents (1995), Woodbine House, Baltimore
25. Zachor D.A., Mroczek-Musulman E., and Brown P. Prevalence of celiac disease in Down syndrome in the United States. J Pediatr Gastroenterol Nutr 31 (2000) 275-279
26. Allison D.B., Gomez J.E., and Heshka S. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord 19 (1995) 858-861
27. Shott S.R., Joseph A., and Heithaus D. Hearing loss in children with Down syndrome. Int J Pediatr Otorhinolaryngol 61 (2001) 199-205
28. Sare Z., Ruvalcaba R.H., and Kelley V.C. Prevalence of thyroid disorder in Down syndrome. Clin Genet (1978) 154-158
29. Cohen W.I. Health care guidelines for individuals with Down syndrome: 1999 revision. Down Syndr Q 4 (1999) 1-16
30. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's Syndrome. Br J Haematol 110 (2000) 512-524
31. Rogers P.T., Roizen N.J., and Capone G.T. Down syndrome. In: Capute A.J., and Accardo P.J. (Eds). Developmental disabilities in infancy and childhood. 2nd edition (1996), Brookes Publishing, Baltimore 221-244
32. Pueschel S.M., and Scola F.H. Atlantoaxial instability in individuals with Down Syndrome: epidemiologic, radiographic, and clinical studies. Pediatrics 80 (1987) 555-560
33. Myers B.A., and Pueschel S.M. Psychiatric disorders in persons with Down Syndrome. J Nerv Ment Dis 179 (1991) 609-613
34. Rice C., and Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR CDC Surveill Summ 56 (2007) 12-28
35. Cohen W.I., and Patterson B. Neurodevelopmental disorders in Down syndrome. In: Hassold T.J., and Patterson D. (Eds). Down syndrome: a promising future, together (1999), Wiley-Liss, New York 45-51
36. Dalton A.J., and Crapper-McLachlan D.R. Clinical expression of Alzheimer's disease in Down Syndrome. Psychiatr Clin North Am 9 (1986) 659-670
37. Sharav T., and Bowman T. Dietary practices, physical activity, and body-mass index in a selected population of Down syndrome children and their siblings. Clin Pediatr (Phila) 31 (1992) 341-344
38. Cronk C., Crocker A.C., Pueschel S.M., Shea A.M., Zackai E., Pickens G., et al. Growth charts for children with Down Syndrome: 1 month to 18 years of age. Pediatrics 81 (1988) 102-110
39. Cronk C.E., Chumlea W.C., and Roche A.F. Assessment of overweight children with trisomy 21. Am J Ment Defic 89 (1985) 433-436
40. Styles M.E., Cole T.J., Dennis J., and Preece M.A. New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Arch Dis Child 87 (2002) 104-108
41. Al Husain M. Growth charts for children with Down's syndrome in Saudi Arabia: birth to 5 years. Int J Clin Pract 57 (2003) 170-174
42. Melyn M.A., and White M.A. Mental and developmental milestones of noninstitutionalized Down's syndrome children. Pediatrics 52 (1973) 542-545
43. Connolly B.H., Morgan S.B., Russell F.F., and Fulliton W.L. A longitudinal study of children with Down syndrome who experienced early intervention programming. Phys Ther 73 (1993) 170-179
44. Libb J.W., Myers G.J., Graham E., and Bell B. Correlates of intelligence and adaptive behaviour in Down's syndrome. J Ment Defic Res (1983) 205-210
45. Clements P.R., Bates M.V., and Hafer M. Variability within Down's syndrome (trisomy-21): empirically observed sex differences in IQs. Ment Retard 14 (1976) 30-31
46. Mahoney G., Perales F., Wiggers B., and Herman B. Responsive teaching: early intervention for children with Down syndrome and other disabilities. Downs Syndr Res Pract 11 (2006) 18-28
47. Carr J. Six weeks to twenty-one years old: a longitudinal study of children with Down's syndrome and their families. Third Jack Tizard memorial lecture. J Child Psychol Psychiatry 29 (1988) 407-431
48. Shepperdson B. Two longitudinal studies of the abilities of people with Down's syndrome. J Intellect Disabil Res 39 (1995) 419-431
49. Wishart J.G. Development in children with Down syndrome: facts, findings, the future. Int J Disabil Dev Educ 45 (1998) 343-363
50. Silverman W. Down syndrome: cognitive phenotype. Ment Retard Dev Disabil Res Rev 13 (2007) 228-236
51. Chapman R.S. Language and cognitive development in children and adolescents with Down syndrome. In: Miller J.F., Leavitt L.A., and Leddy M. (Eds). Improving the communication of people with Down syndrome (1999), Brookes Publishing, Baltimore 99-110
52. Wang P.P. A neuropsychological profile of Down syndrome: cognitive skills and brain morphology. Ment Retard Dev Disabil Res Rev 2 (1996) 102-108
53. Fidler D.J., and Nadel L. Education and children with Down syndrome: neuroscience, development, and intervention. Ment Retard Dev Disabil Res Rev 13 (2007) 262-271
54. Chapman R.S., and Hesketh L.J. Language, cognition, and short-term memory in individuals with Down syndrome. Downs Syndr Res Pract 7 (2001) 1-7
55. Kumin L. Speech intelligibility and childhood verbal apraxia in children with Down syndrome. Downs Syndr Res Pract 10 (2006) 10-22
56. Carlesimo G.A., Marotta L., and Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35 (1997) 71-79
57. Wang P.P., and Bellugi U. Evidence from two genetic syndromes for a dissociation between verbal and visual-spatial short-term memory. J Clin Exp Neuropsychol 16 (1994) 317-322
58. Vicari S., Verucci L., and Carlesimo G.A. Implicit memory is independent from IQ and age but not from etiology: evidence from Down and Williams syndromes. J Intellect Disabil Res 51 (2007) 932-941
59. Chapman R.S. Language learning in Down syndrome: the speech and language profile compared to adolescents with cognitive impairment of unknown origin. Downs Syndr Res Pract 10 (2006) 61-66
60. Jarrold C., Baddeley A.D., and Phillips C. Long-term memory for verbal and visual information in Down syndrome and Williams syndrome: performance on the Doors and People test. Cortex 43 (2007) 233-247
61. Roizen N.J. Down syndrome. In: Batshaw M.L. (Ed). Children with disabilities. 5th Edition (2002), Brookes Publishing, Baltimore 307-320
62. Dykens E.M., Shah B., Sagun J., Beck T., and King B.H. Maladaptive behaviour in children and adolescents with Down's syndrome. J Intellect Disabil Res 46 (2002) 484-492
63. Dykens E.M., and Kasari C. Maladaptive behavior in children with Prader-Willi syndrome. Down syndrome, and nonspecific mental retardation. Am J Men Retard 102 (1997) 228-237
64. Bhatia M.S., Kabra M., and Sapra S. Behavioral problems in children with Down syndrome. Indian Pediatr 42 (2005) 675-680
65. Cuskelly M., and Dadds M. Behavioural problems in children with Down's syndrome and their siblings. J Child Psychol Psychiatry 33 (1992) 749-761
66. Coe D.A., Matson J.L., Russell D.W., Slifer K.J., Capone G.T., Baglio C., et al. Behavior problems of children with Down syndrome and life events. J Autism Dev Disord 29 (1999) 149-156
67. Fidler D.J., Barrett K.C., and Most D.E. Age-related differences in smiling and personality in Down syndrome. J Dev Phys Disabil 17 (2005) 263-280
68. Sheridan R., Llerena J.J., and Matkins S. Fertility in a male with Trisomy 21. J Med Genet 26 (1989) 294-298
69. Special Olympics: Coach > Coaching Guides > Basics of Special Olympics > Down Syndrome and Restrictions Based on Atlantoaxial Instability. Participation by Individuals with Down Syndrome Who have Atlantoaxial Instability. Washington DC. Special Olympics International. Available at: www.specialolympics.org/English/Coach/Coaching Guides/Basics of Special Olympics/Down Syndrome and restrictions based on atlantoaxial instability/Participation by individuals with Down syndrome who have atlantoaxial instability. Accessed August 5, 2008.
70. Guralnick M.J. The effectiveness of early intervention for vulnerable children: a developmental perspective. Am J Men Retard 102 (1998) 319-345
71. U.S. Department of Education. Building the Legacy: IDEA 2004. Available at http://idea.ed.gov. Accessed August 5, 2008.
72. Conlon C.J. Early intervention. In: Batshaw M.L. (Ed). Children with disabilities. 5th Edition (2002), Brookes Publishing, Baltimore 579-588
73. Roid G.H. Stanford-Binet intelligence scales. 5th Edition (2003), Riverside Publishing, Rolling Meadows, IL
74. Goldstein H., Schneider N., and Thiemann K. Peer-mediated social communication intervention: when clinical expertise informs treatment development and evaluation. Top Lang Disord 27 (2007) 182-199
75. Buckley S., Bird G., Sacks B., and Archer T. A comparison of mainstream and special education for teenagers with Down syndrome: implications for parents and teachers. Downs Syndr Res Pract 9 (2006) 54-67
76. Wishart J. Motivation and learning styles in young children with Down syndrome. Downs Syndr Res Pract 7 (2001) 47-51
77. Feeley K.M., and Jones E.A. Addressing challenging behaviour in children with Down syndrome: the use of applied behaviour analysis for assessment and intervention. Downs Syndr Res Pract 11 (2006) 64-77
78. Fidler D.J., Most D.E., Booth-LaForce C., and Kelly J.F. Temperament and behaviour problems in young children with Down syndrome at 12, 30, and 45 months. Downs Syndr Res Pract 10 (2006) 23-29
79. Prussing E., Sobo E., Walker E., Dennis K., and Kurtin P.S. Communication with pediatricians about complementary/alternative medicine: perspectives from parents of children with Down Syndrome. Ambul Pediatr 4 (2004) 488-494
80. Roizen N. Complementary and alternative therapies for Down syndrome. Ment Retard Dev Disabil Res Rev 11 (2005) 149-155
81. Adams S.K. Complementary and alternative medicine: basic information and guidelines for use. Brown Univ Child Adolesc Behav Lett 24 (2008) 1-7
82. Salman M.S. Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome. Eur J Paediatr Neurol 6 (2002) 213-219
83. Van Dyke D.C., Lang D.J., van Duyne S., Heide F., and Change H. Cell therapy in children with Down syndrome: a retrospective study. Pediatrics 85 (1990) 79-84
84. Lobaugh N.J., Karaskov V., Rombough V., Rovet J., Bryson S., Greenbaum R., et al. Piracetam therapy does not enhance cognitive functioning in children with Down Syndrome. Arch Pediatr Adolesc Med 155 (2001) 442-448
85. Heller J.H., Spiridigliozzi G.A., Crissman B.G., Sullivan J.A., Eells R.L., Li J.S., et al. Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study. J Adol Psychopharmacol 16 (2006) 755-765
86. Prussing E., Sobo E., Walker E., and Kurtin P.S. Between 'desperation' and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome. Soc Sci Med 60 (2005) 587-598
87. Jobling A., and Cuskelly M. Young people with Down syndrome: a preliminary investigation of health knowledge and associated behaviors. J Intellect Dev Disabil 31 (2006) 210-218
88. Ouellette-Kuntz H. Understanding health disparities and inequities faced by individuals with Intellectual Disabilities. J Appl Res Intellect Disabil 18 (2005) 113-121
89. Sadovnick A.D., and Baird P.A. Life expectancy. In: Pueschel S.M., and Pueschel J.K. (Eds). Biomedical concerns in persons with Down syndrome (1992), Brookes Publishing, Baltimore 47-57
90. Hanson M.J. Twenty-five years after early intervention. A follow-up study of children with Down syndrome and their families. Infants Young Child 16 (2003) 354-365
91. Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., et al. The DNA sequence of human chromosome 21. Nature 405 (2000) 311-319
92. Antonarakis S.E., Lyle R., Dermitzakis E.T., Reymond A., and Deutsch S. Chromosome 21 and Down Syndrome: from genomics to pathophysiology. Nature 5 (2004) 725-735
93. Roubertoux P.L., and Kerdelhue B.K. Trisomy 21: from chromosomes to mental retardation. Behav Genet 36 (2006) 346-354